In a little over a month Sanofi will report third quarter results and a big question is will they also announce that finally at long last they have decided to divest their diabetes franchise. We’ve been anticipating such a move since the day Paul Hudson took over as CEO. Since taking over Mr. Hudson has been reshaping Sanofi for the future and with the diabetes franchise struggling it just might be time to bite the bullet.
Whether or not this move is made, and we think it will be there is no question the insulin market is . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.